<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35426438</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>20</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1755-3245</ISSN><JournalIssue CitedMedium="Internet"><Volume>118</Volume><Issue>17</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>18</Day></PubDate></JournalIssue><Title>Cardiovascular research</Title><ISOAbbreviation>Cardiovasc Res</ISOAbbreviation></Journal><ArticleTitle>Neutrophil inhibition improves acute inflammation in a murine model of viral myocarditis.</ArticleTitle><Pagination><StartPage>3331</StartPage><EndPage>3345</EndPage><MedlinePgn>3331-3345</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/cvr/cvac052</ELocationID><Abstract><AbstractText Label="AIMS">Viral myocarditis (VM) is an inflammatory pathology of the myocardium triggered by a viral infection that may cause sudden death or heart failure (HF), especially in the younger population. Current treatments only stabilize and improve cardiac function without resolving the underlying inflammatory cause. The factors that induce VM to progress to HF are still uncertain, but neutrophils have been increasingly associated with the negative evolution of cardiac pathologies. The present study investigates the contribution of neutrophils to VM disease progression in different ways.</AbstractText><AbstractText Label="METHODS AND RESULTS">In a coxsackievirus B3- (CVB3) induced mouse model of VM, neutrophils and neutrophil extracellular traps (NETs) were prominent in the acute phase of VM as revealed by enzyme-linked immunosorbent assay analysis and immunostaining. Anti-Ly6G-mediated neutrophil blockade starting at model induction decreased cardiac necrosis and leucocyte infiltration, preventing monocyte and Ly6CHigh pro-inflammatory macrophage recruitment. Furthermore, genetic peptidylarginine deiminase 4-dependent NET blockade reduced cardiac damage and leucocyte recruitment, significantly decreasing cardiac monocyte and macrophage presence. Depleting neutrophils with anti-Ly6G antibodies at 7 days post-infection, after the acute phase, did not decrease cardiac inflammation.</AbstractText><AbstractText Label="CONCLUSION">Collectively, these results indicate that the repression of neutrophils and the related NET response in the acute phase of VM improves the pathological phenotype by reducing cardiac inflammation.</AbstractText><CopyrightInformation>© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Carai</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-0718-4773</Identifier><AffiliationInfo><Affiliation>Centre for Vascular and Molecular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CARIM, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>González</LastName><ForeName>Laura Florit</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Centre for Vascular and Molecular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Experimental Cardiology Laboratory, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Bruggen</LastName><ForeName>Stijn</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5572-2196</Identifier><AffiliationInfo><Affiliation>Centre for Vascular and Molecular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spalart</LastName><ForeName>Valerie</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Centre for Vascular and Molecular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Giorgio</LastName><ForeName>Daria</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-9704-1524</Identifier><AffiliationInfo><Affiliation>Centre for Vascular and Molecular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri, IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geuens</LastName><ForeName>Nadéche</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Centre for Vascular and Molecular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinod</LastName><ForeName>Kimberly</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-1026-6107</Identifier><AffiliationInfo><Affiliation>Centre for Vascular and Molecular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Elizabeth Anne Vincent</ForeName><Initials>EAV</Initials><Identifier Source="ORCID">0000-0002-2006-7064</Identifier><AffiliationInfo><Affiliation>Centre for Vascular and Molecular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CARIM, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heymans</LastName><ForeName>Stephane</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9477-7803</Identifier><AffiliationInfo><Affiliation>Centre for Vascular and Molecular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CARIM, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cardiovasc Res</MedlineTA><NlmUniqueID>0077427</NlmUniqueID><ISSNLinking>0008-6363</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="Y">Virus Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coxsackievirus B3</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Neutrophil extracellular traps</Keyword><Keyword MajorTopicYN="N">Neutrophils</Keyword><Keyword MajorTopicYN="N">Viral myocarditis</Keyword></KeywordList><CoiStatement>Conflict of interest: S.H. receives personal fees for scientific advice to Astra-Zeneca, Cellprothera, CSL Behring, and Merck; unrestricted research grant from Pfizer. K.M. has received consulting fees for scientific advice to PEEL Therapeutics. All the remaining authors, P.C., L.F.G., S.V.B., V.S., D.D.G., N.G., and E.A.V.J., declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>15</Day><Hour>8</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35426438</ArticleId><ArticleId IdType="pmc">PMC9847559</ArticleId><ArticleId IdType="doi">10.1093/cvr/cvac052</ArticleId><ArticleId IdType="pii">6568912</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fabre A, Sheppard MN. Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death. Heart 2006;92:316–320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1860827</ArticleId><ArticleId IdType="pubmed">15923280</ArticleId></ArticleIdList></Reference><Reference><Citation>Weintraub RG, Semsarian C, Macdonald P. Dilated cardiomyopathy. Lancet 2017;390:400–414.</Citation><ArticleIdList><ArticleId IdType="pubmed">28190577</ArticleId></ArticleIdList></Reference><Reference><Citation>Tschöpe C, Ammirati E, Bozkurt B, Caforio ALP, Cooper LT, Felix SB, Hare JM, Heidecker B, Heymans S, Hübner N, Kelle S, Klingel K, Maatz H, Parwani AS, Spillmann F, Starling RC, Tsutsui H, Seferovic P, van Linthout S. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol 2021;18:169–193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7548534</ArticleId><ArticleId IdType="pubmed">33046850</ArticleId></ArticleIdList></Reference><Reference><Citation>Corsten MF, Schroen B, Heymans S. Inflammation in viral myocarditis: friend or foe? Trends Mol Med 2012;18:426–437.</Citation><ArticleIdList><ArticleId IdType="pubmed">22726657</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola V-P, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. E Heart J 2016;37:2129–2200.</Citation><ArticleIdList><ArticleId IdType="pubmed">27894487</ArticleId></ArticleIdList></Reference><Reference><Citation>Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992;80:2012–2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">1382715</ArticleId></ArticleIdList></Reference><Reference><Citation>Denning N-L, Aziz M, Sd G, Wang P. DAMPs and NETs in sepsis. Front Immunol 2019;10:2536.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6831555</ArticleId><ArticleId IdType="pubmed">31736963</ArticleId></ArticleIdList></Reference><Reference><Citation>Frantz S, Falcao-Pires I, Balligand JL, Bauersachs J, Brutsaert D, Ciccarelli M, Dawson D, de Windt LJ, Giacca M, Hamdani N, Hilfiker-Kleiner D, Hirsch E, Leite-Moreira A, Mayr M, Thum T, Tocchetti CG, van der Velden J, Varricchi G, Heymans S. The innate immune system in chronic cardiomyopathy: a European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC. Eur J Heart Fail 2018;20:445–459.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5993315</ArticleId><ArticleId IdType="pubmed">29333691</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 2011;11:519–531.</Citation><ArticleIdList><ArticleId IdType="pubmed">21785456</ArticleId></ArticleIdList></Reference><Reference><Citation>Sørensen OE, Borregaard N. Neutrophil extracellular traps - the dark side of neutrophils. J Clin Invest 2016;126:1612–1620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4855925</ArticleId><ArticleId IdType="pubmed">27135878</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaul DS, Stein S, Matter CM. Neutrophils in cardiovascular disease. Eur Heart J 2017;38:1702–1704.</Citation><ArticleIdList><ArticleId IdType="pubmed">30052884</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorvillo N, Cherpokova D, Martinod K, Wagner DD. Extracellular DNA NET-works with dire consequences for health. Circ Res 2019;125:470–488.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6746252</ArticleId><ArticleId IdType="pubmed">31518165</ArticleId></ArticleIdList></Reference><Reference><Citation>Schönrich G, Raftery MJ. Neutrophil extracellular traps go viral. Front Immunol 2016;7:366.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5027205</ArticleId><ArticleId IdType="pubmed">27698656</ArticleId></ArticleIdList></Reference><Reference><Citation>Aroca-Crevillén A, Adrover JM, Hidalgo A. Circadian features of neutrophil biology. Front Immunol 2020;11:576.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7169427</ArticleId><ArticleId IdType="pubmed">32346378</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmers S, Teijaro JR, Arandjelovic S, Mowen KA. PAD4-mediated neutrophil extracellular trap formation is not required for immunity against influenza infection. PLoS One 2011;6:e22043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3133614</ArticleId><ArticleId IdType="pubmed">21779371</ArticleId></ArticleIdList></Reference><Reference><Citation>Passegué E, Wagner EF, Weissman IL. JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells. Cell 2004;119:431–443.</Citation><ArticleIdList><ArticleId IdType="pubmed">15507213</ArticleId></ArticleIdList></Reference><Reference><Citation>Faul F, Erdfelder E, Buchner A, Lang A-G. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 2009;41:1149–1160.</Citation><ArticleIdList><ArticleId IdType="pubmed">19897823</ArticleId></ArticleIdList></Reference><Reference><Citation>Rienks M, Papageorgiou A, Wouters K, Verhesen W, van Leeuwen R, Carai P, Summer G, Westermann D, Heymans S. A novel 72-kDa leukocyte-derived osteoglycin enhances the activation of toll-like receptor 4 and exacerbates cardiac inflammation during viral myocarditis. Cell Mol Life Sci 2017;74:1511–1525.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5357299</ArticleId><ArticleId IdType="pubmed">27878326</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderbeke L, van Mol P, van Herck Y, de Smet F, Humblet-Baron S, Martinod K, Antoranz A, Arijs I, Boeckx B, Bosisio FM, Casaer M, Dauwe D, de Wever W, Dooms C, Dreesen E, Emmaneel A, Filtjens J, Gouwy M, Gunst J, Hermans G, Jansen S, Lagrou K, Liston A, Lorent N, Meersseman P, Mercier T, Neyts J, Odent J, Panovska D, Penttila PA, Pollet E, Proost P, Qian J, Quintelier K, Raes J, Rex S, Saeys Y, Sprooten J, Tejpar S, Testelmans D, Thevissen K, van Buyten T, Vandenhaute J, van Gassen S, Velásquez Pereira LC, Vos R, Weynand B, Wilmer A, Yserbyt J, Garg AD, Matthys P, Wouters C, Lambrechts D, Wauters E, Wauters J. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity. Nat Commun 2021;12:4117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8257697</ArticleId><ArticleId IdType="pubmed">34226537</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez J-Y, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A. Fiji: an open-source platform for biological-image analysis. Nat Methods 2012;9:676–682.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3855844</ArticleId><ArticleId IdType="pubmed">22743772</ArticleId></ArticleIdList></Reference><Reference><Citation>Deckx S, Heggermont W, Carai P, Rienks M, Dresselaers T, Himmelreich U, van Leeuwen R, Lommen W, van der Velden J, Gonzalez A, Diez J, Papageorgiou A-P, Heymans S. Osteoglycin prevents the development of age-related diastolic dysfunction during pressure overload by reducing cardiac fibrosis and inflammation. Matrix Biol 2018;66:110–124.</Citation><ArticleIdList><ArticleId IdType="pubmed">28958774</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinod K, Demers M, Fuchs TA, Wong SL, Brill A, Gallant M, Hu J, Wang Y, Wagner DD. Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice. Proc Natl Acad Sci USA 2013;110:8674–8679.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3666755</ArticleId><ArticleId IdType="pubmed">23650392</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen AD, Skov S, Haase C. The role of neutrophils and G-CSF in DNFB-induced contact hypersensitivity in mice. Immunity Inflamm Dis 2014;2:21–34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4220669</ArticleId><ArticleId IdType="pubmed">25400922</ArticleId></ArticleIdList></Reference><Reference><Citation>Tecchio C, Micheletti A, Cassatella MA. Neutrophil-derived cytokines: facts beyond expression. Front Immunol 2014;5:508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4204637</ArticleId><ArticleId IdType="pubmed">25374568</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruytinx P, Proost P, van Damme J, Struyf S. Chemokine-induced macrophage polarization in inflammatory conditions. Front Immunol 2018;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6137099</ArticleId><ArticleId IdType="pubmed">30245686</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimura T, Baba T, Midwood KS, Gschwandtner M, Derler R. More than just attractive: how CCL2 influences myeloid cell behavior beyond chemotaxis. Front Immunol 2019;10:2759.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6923224</ArticleId><ArticleId IdType="pubmed">31921102</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P, Li M, Lindberg MR, Kennett MJ, Xiong N, Wang Y. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med 2010;207:1853–1862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2931169</ArticleId><ArticleId IdType="pubmed">20733033</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivadeneyra L, Charó N, Kviatcovsky D, de La Barrera S, Martín Gómez R, Schattner M, Charo N, Kviatcovsky D, de La Barrera S, Gómez RM, Schattner M. Role of neutrophils in CVB3 infection and viral myocarditis. J Mol Cell Cardiol 2018;125:149–161.</Citation><ArticleIdList><ArticleId IdType="pubmed">30393107</ArticleId></ArticleIdList></Reference><Reference><Citation>Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004;303:1526–1529.</Citation><ArticleIdList><ArticleId IdType="pubmed">14976262</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu D, Wang P, Yang J, Qian Q, Li M, Wei L, Xu W. Gr-1+ cells other than Ly6G+ neutrophils limit virus replication and promote myocardial inflammation and fibrosis following coxsackievirus B3 infection of mice. Front Cell Infect Microbiol 2018;8:157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5962688</ArticleId><ArticleId IdType="pubmed">29868513</ArticleId></ArticleIdList></Reference><Reference><Citation>Egan CE, Sukhumavasi W, Bierly AL, Denkers EY. Understanding the multiple functions of Gr-1 + cell subpopulations during microbial infection. Immunol Res 2008;40:35–48.</Citation><ArticleIdList><ArticleId IdType="pubmed">18193362</ArticleId></ArticleIdList></Reference><Reference><Citation>Robben PM, LaRegina M, Kuziel WA, Sibley LD. Recruitment of Gr-1 + monocytes is essential for control of acute toxoplasmosis. J Exp Med 2005;201:1761–1769.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2213275</ArticleId><ArticleId IdType="pubmed">15928200</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronte V, Brandau S, Chen S-H, Colombo MP, Frey AB, Greten TF, Mandruzzato S, Murray PJ, Ochoa A, Ostrand-Rosenberg S, Rodriguez PC, Sica A, Umansky V, Vonderheide RH, Gabrilovich DI. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun 2016;7:12150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4935811</ArticleId><ArticleId IdType="pubmed">27381735</ArticleId></ArticleIdList></Reference><Reference><Citation>Carai P, Papageorgiou AP, van Linthout DS, Velthuis S, Lutgens E, Wijnands E, Tschöpe C, Schmuttermaier C, Kzhyshkowska J, Anne E, Jones V, Heymans S. Stabilin-1 mediates beneficial monocyte recruitment and tolerogenic macrophage programming during CVB3-induced viral myocarditis. J Mol Cell Cardiol 2022;165:31–39.</Citation><ArticleIdList><ArticleId IdType="pubmed">34968453</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee TD, Gonzalez ML, Kumar P, Grammas P, Pereira HA. CAP37, a neutrophil-derived inflammatory mediator, augments leukocyte adhesion to endothelial monolayers. Microvasc Res 2003;66:38–48.</Citation><ArticleIdList><ArticleId IdType="pubmed">12826073</ArticleId></ArticleIdList></Reference><Reference><Citation>Soehnlein O, Zernecke A, Eriksson EE, Rothfuchs AG, Pham CT, Herwald H, Bidzhekov K, Rottenberg ME, Weber C, Lindbom L. Neutrophil secretion products pave the way for inflammatory monocytes. Blood 2008;112:1461–1471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3400540</ArticleId><ArticleId IdType="pubmed">18490516</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertov O, Ueda H, Xu LL, Tani K, Murphy WJ, Wang JM, Howard OMZ, Sayers TJ, Oppenheim JJ. Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J Exp Med 1997;186:739–747.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2199011</ArticleId><ArticleId IdType="pubmed">9271589</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung YS, Lee HY, Kim SD, Park JS, Kim JK, Suh P-G, Bae Y-S. Wnt5a stimulates chemotactic migration and chemokine production in human neutrophils. Exp Mol Med 2013;45:e27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3701286</ArticleId><ArticleId IdType="pubmed">23764954</ArticleId></ArticleIdList></Reference><Reference><Citation>de Filippo K, Henderson RB, Laschinger M, Hogg N. Neutrophil chemokines KC and macrophage-inflammatory protein-2 are newly synthesized by tissue macrophages using distinct TLR signaling pathways. J Immunol 2008;180:4308–4315.</Citation><ArticleIdList><ArticleId IdType="pubmed">18322244</ArticleId></ArticleIdList></Reference><Reference><Citation>Capucetti A, Albano F, Bonecchi R. Multiple roles for chemokines in neutrophil biology. Front Immunol 2020;11:1259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7363767</ArticleId><ArticleId IdType="pubmed">32733442</ArticleId></ArticleIdList></Reference><Reference><Citation>Boro M, Balaji KN. CXCL1 and CXCL2 regulate NLRP3 inflammasome activation via G-Protein–coupled receptor CXCR2. J Immunol 2017;199:1660–1671.</Citation><ArticleIdList><ArticleId IdType="pubmed">28739876</ArticleId></ArticleIdList></Reference><Reference><Citation>Soehnlein O, Kenne E, Rotzius P, Eriksson EE, Lindbom L. Neutrophil secretion products regulate anti-bacterial activity in monocytes and macrophages. Clin Exp Immunol 2007;151:139–145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2276935</ArticleId><ArticleId IdType="pubmed">17991288</ArticleId></ArticleIdList></Reference><Reference><Citation>Soehnlein O, Kai-Larsen Y, Frithiof R, Sorensen OE, Kenne E, Scharffetter-Kochanek K, Eriksson EE, Herwald H, Agerberth B, Lindbom L. Neutrophil primary granule proteins HBP and HNP1–3 boost bacterial phagocytosis by human and murine macrophages. J Clin Invest 2008;118:3491–3502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2532980</ArticleId><ArticleId IdType="pubmed">18787642</ArticleId></ArticleIdList></Reference><Reference><Citation>Altara R, Mallat Z, Booz GW, Zouein FA. The CXCL10/CXCR3 axis and cardiac inflammation: implications for immunotherapy to treat infectious and noninfectious diseases of the heart. J Immunol Res 2016;2016:1–12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5066021</ArticleId><ArticleId IdType="pubmed">27795961</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichikawa A, Kuba K, Morita M, Chida S, Tezuka H, Hara H, Sasaki T, Ohteki T, Ranieri VM, dos Santos CC, Kawaoka Y, Akira S, Luster AD, Lu B, Penninger JM, Uhlig S, Slutsky AS, Imai Y. CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin. Am J Respir Crit Care Med 2013;187:65–77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3927876</ArticleId><ArticleId IdType="pubmed">23144331</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey V, Martinez AKF, Bastea LI, Döppler HR, Eisenhauer J, Le T, Edenfield B, Storz P. Cxcl10/cxcr3 signaling contributes to an inflammatory microenvironment and its blockade enhances progression of murine pancreatic precancerous lesions. eLife 2021;10:e60646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8360647</ArticleId><ArticleId IdType="pubmed">34328416</ArticleId></ArticleIdList></Reference><Reference><Citation>Scannell M, Flanagan MB, deStefani A, Wynne KJ, Cagney G, Godson C, Maderna P. Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J Immunol 2007;178:4595–4605.</Citation><ArticleIdList><ArticleId IdType="pubmed">17372018</ArticleId></ArticleIdList></Reference><Reference><Citation>Soehnlein O, Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 2010;10:427–439.</Citation><ArticleIdList><ArticleId IdType="pubmed">20498669</ArticleId></ArticleIdList></Reference><Reference><Citation>Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol 2018;18:134–147.</Citation><ArticleIdList><ArticleId IdType="pubmed">28990587</ArticleId></ArticleIdList></Reference><Reference><Citation>Borissoff JI, Joosen IA, Versteylen MO, Brill A, Fuchs TA, Savchenko AS, Gallant M, Martinod K, ten Cate H, Hofstra L, Crijns HJ, Wagner DD, Kietselaer BLJH. Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state. Arterioscler Thromb Vasc Biol 2013;33:2032–2040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3806482</ArticleId><ArticleId IdType="pubmed">23818485</ArticleId></ArticleIdList></Reference><Reference><Citation>Savchenko AS, Borissoff JI, Martinod K, de Meyer SF, Gallant M, Erpenbeck L, Brill A, Wang Y, Wagner DD. VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia/reperfusion injury in mice. Blood 2014;123:141–148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3879903</ArticleId><ArticleId IdType="pubmed">24200682</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinod K, Witsch T, Erpenbeck L, Savchenko A, Hayashi H, Cherpokova D, Gallant M, Mauler M, Cifuni SM, Wagner DD. Peptidylarginine deiminase 4 promotes age-related organ fibrosis. J Exp Med 2017;214:439–458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5294849</ArticleId><ArticleId IdType="pubmed">28031479</ArticleId></ArticleIdList></Reference><Reference><Citation>Weckbach LT, Grabmaier U, Uhl A, Gess S, Boehm F, Zehrer A, Pick R, Salvermoser M, Czermak T, Pircher J, Sorrelle N, Migliorini M, Strickland DK, Klingel K, Brinkmann V, Abu Abed U, Eriksson U, Massberg S, Brunner S, Walzog B. Midkine drives cardiac inflammation by promoting neutrophil trafficking and NETosis in myocarditis. J Exp Med 2019;216:350–368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6363424</ArticleId><ArticleId IdType="pubmed">30647120</ArticleId></ArticleIdList></Reference><Reference><Citation>Dömer D, Walther T, Möller S, Behnen M, Laskay T. Neutrophil extracellular traps activate proinflammatory functions of human neutrophils. Front Immunol 2021;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8217666</ArticleId><ArticleId IdType="pubmed">34168641</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahlenberg JM, Carmona-Rivera C, Smith CK, Kaplan MJ. Neutrophil extracellular trap–associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages. J Immunol 2013;190:1217–1226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3552129</ArticleId><ArticleId IdType="pubmed">23267025</ArticleId></ArticleIdList></Reference><Reference><Citation>Warnatsch A, Ioannou M, Wang Q, Papayannopoulos V. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science 2015;349:316–320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4854322</ArticleId><ArticleId IdType="pubmed">26185250</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W, Wang Q, Ke Y, Lin J. Neutrophil function in an inflammatory milieu of rheumatoid arthritis. J Immunol Res 2018;2018:1–12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6304923</ArticleId><ArticleId IdType="pubmed">30622982</ArticleId></ArticleIdList></Reference><Reference><Citation>Corsten MF, Papageorgiou A, Verhesen W, Carai P, Lindow M, Obad S, Summer G, Coort SLM, Hazebroek M, van Leeuwen R, Gijbels MJJ, Wijnands E, Biessen EAL, de Winther MPJ, Stassen FRM, Carmeliet P, Kauppinen S, Schroen B, Heymans S. MicroRNA profiling identifies MicroRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis. Circ Res 2012;111:415–425.</Citation><ArticleIdList><ArticleId IdType="pubmed">22715471</ArticleId></ArticleIdList></Reference><Reference><Citation>Corsten MF, Heggermont W, Papageorgiou A-PP, Deckx S, Tijsma A, Verhesen W, van Leeuwen R, Carai P, Thibaut H-JJ, Custers K, Summer G, Hazebroek M, Verheyen F, Neyts J, Schroen B, Heymans S. The microRNA-221/-222 cluster balances the antiviral and inflammatory response in viral myocarditis. Eur Heart J 2015;36:2909–2919.</Citation><ArticleIdList><ArticleId IdType="pubmed">26206211</ArticleId></ArticleIdList></Reference><Reference><Citation>Deckx S, Johnson DM, Rienks M, Carai P, van Deel E, van der Velden J, Sipido KR, Heymans S, Papageorgiou A-P. Extracellular SPARC increases cardiomyocyte contraction during health and disease. PLoS One 2019;14:e0209534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6443176</ArticleId><ArticleId IdType="pubmed">30933983</ArticleId></ArticleIdList></Reference><Reference><Citation>Bie P, Debrabant B. Gonadal sex and animal experimentation: perfection vs. 3R principle? Basic Clin Pharmacol Toxicol 2020;127:111–119.</Citation><ArticleIdList><ArticleId IdType="pubmed">32267064</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>